— Know what they know.
Not Investment Advice

RTGN OTC

RetinalGenix Technologies Inc.
1W: +0.0% 1M: -0.2% 3M: -0.2% YTD: +24.7% 1Y: +12.7% 3Y: -44.2%
$3.99
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Devices · Tech Score Sell · Power 43 · $75.2M mcap · 6M float · 0.0001% daily turnover · Short 97% of daily vol

📊 Key Metrics

TTM
$0M
Revenue
-100.0% YoY
$-2M
Net Income
+24.0% YoY
$-0M
Free Cash Flow
+37.1% YoY
0.0%
Gross Margin
0.0%
Op. Margin
0.0%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE90.4%
ROA-10293.8%
ROIC-10.3%

Valuation

P/E-36.0
P/B-28.4
EV/EBITDA218.4

Leverage

Debt/Equity-0.02
Current Ratio0.01
Interest Cov.47.2x

Quality Scores

Piotroski F4/9
Altman Z-861.65
Beneish M0.00

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms